Sophie Wittenburg - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sophie Wittenburg

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Chemical Communications (Cambridge, England)|July 19, 2022

Targeting the deubiquitinase USP7 for degradation with PROTACsArunima Murgai, Izidor Sosič, Martina Gobec, et al.

Chemmedchem|January 31, 2022

Andrographolide Derivatives Target the KEAP1/NRF2 Axis and Possess Potent Anti-SARS-CoV-2 ActivityBianca Schulte, Maria König, Beate I Escher, et al.

Journal of Medicinal Chemistry|July 17, 2025

Enhancing Solubility in VHL-Based PROTACs: Optimized USP7 Degraders for Improved DevelopabilitySophie Wittenburg, Maximilian R Zuleeg, Kirsten Peter, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Chemical Communications (Cambridge, England)|July 19, 2022

Targeting the deubiquitinase USP7 for degradation with PROTACsArunima Murgai, Izidor Sosič, Martina Gobec, et al.

Chemmedchem|January 31, 2022

Andrographolide Derivatives Target the KEAP1/NRF2 Axis and Possess Potent Anti-SARS-CoV-2 ActivityBianca Schulte, Maria König, Beate I Escher, et al.

Journal of Medicinal Chemistry|July 17, 2025

Enhancing Solubility in VHL-Based PROTACs: Optimized USP7 Degraders for Improved DevelopabilitySophie Wittenburg, Maximilian R Zuleeg, Kirsten Peter, et al.

Pageof 1